Apoptosis in Laminin alpha2-Deficient Muscle Pathology
层粘连蛋白 α2 缺陷的肌肉病理学中的细胞凋亡
基本信息
- 批准号:7216337
- 负责人:
- 金额:$ 36.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingActivation AnalysisAffectAge of OnsetAge-MonthsAnimalsApoptosisApoptoticBIRC4 geneBasement membraneBax proteinBirthCD8-Positive T-LymphocytesCaspaseCell DeathCell ProliferationCell SurvivalCellsCessation of lifeCritical PathwaysDefectDiseaseDisease ProgressionDisease modelExhibitsExperimental ModelsFiberFutureGenesGrowthHistologyHumanImmunohistochemistryIn Situ Nick-End LabelingIn VitroInflammatoryInflammatory ResponseInhibition of ApoptosisLamininLimb structureLongevityMerosinMethodsMotionMouse StrainsMusMuscleMuscle CellsMuscle FibersMuscle WeaknessMutant Strains MiceMutationMyopathyNatural regenerationNumbersParalysedPathogenesisPathologyPathway interactionsPatternPopulationPrevalenceProcessProtein FamilyProtein OverexpressionProteinsRNA InterferenceRangeRegulationRepressionResearch PersonnelRoleSeveritiesSkeletal MuscleStagingSymptomsTNF geneTenascinTherapeutic InterventionTissuesTransgenesTransgenic OrganismsViralWeaningWeekWestern Blottingapoptotic protease-activating factor 1congenital muscular dystrophydaydesign and constructiongenetic regulatory proteinhuman BIRC3 proteinimprovedin vivoin vivo regenerationmacrophagemutantmyelinationprecursor cellpro-apoptotic proteinprogramsprotein expressionresearch studysize
项目摘要
DESCRIPTION (provided by applicant): Congenital muscular dystrophy is often caused by deficiency in laminin a2 (merosin) expression in the basement membrane surrounding muscle fibers. Merosin-deficient congenital muscular dystrophy (MCMD) is characterized by severe muscle weakness shortly after birth that does not improve significantly enough to allow normal ambulatory motion. The dy mutant mouse lines also lack normal laminin u2 expression and provide an experimental models for this disease. Severe mutants such as the dyw strain undergo muscle fiber degeneration followed by regeneration, but these fibers die in a process involving apoptosis. Ultimately mice die within 4 months of age. We have found that muscle specific overexpression of Bcl-2 (an inhibitor of apoptosis) can significantly prolong the survival dyw mice and improve post-weaning growth thus indicating that regulation of the cell death specifically in muscle cells has a dramatic effect on this disease progression. Additionally, we find that d/v animals deficient in Bax, a related pro-apoptotic protein, exhibit even greater longevity and growth along with reduced hind limb paralysis associated with laminin a2- deficient myelination defects. Experiments are proposed to further explore the role of Bcl-2 and Bax in the progression of laminin a2-deficient muscle pathology and determine their effects on apoptosis, regeneration and survival at both early and later stages of disease. We will also examine expression of other apoptotic regulatory molecules, specifically FLIPL, ARC, XIAP, and Apaf-1, in normal and laminin a2-deficient muscle cells. Expression of these proteins will be experimentally altered in vivo to determine whether or not they can regulate the survival of laminin u2-deficient muscle and if disease progression can be modulated at different stages by altering their levels. These results will further our understanding of mechanisms controlling the apoptotic process during laminin a2-deficient muscle degeneration and possibly identify pathways that could serve as targets for therapeutic intervention in the treatment of human MCMD.
描述(由申请人提供):先天性肌营养不良症通常是由肌纤维周围的基底膜中层粘连蛋白 a2(merosin)表达缺陷引起的。梅罗蛋白缺陷型先天性肌营养不良症 (MCMD) 的特点是出生后不久出现严重的肌肉无力,且没有明显改善,无法进行正常的走动运动。 dy 突变小鼠系也缺乏正常的层粘连蛋白 u2 表达,并为这种疾病提供了实验模型。诸如 dyw 菌株等严重突变体会经历肌纤维变性,然后再生,但这些纤维在涉及细胞凋亡的过程中死亡。最终小鼠在 4 个月龄内死亡。我们发现肌肉特异性过度表达 Bcl-2(细胞凋亡抑制剂)可以显着延长 dyw 小鼠的存活时间并改善断奶后的生长,因此表明肌肉细胞中细胞死亡的调节对该疾病的进展具有显着影响。此外,我们发现缺乏 Bax(一种相关的促凋亡蛋白)的 d/v 动物表现出更长的寿命和生长,同时减少与层粘连蛋白 a2 缺陷髓鞘形成缺陷相关的后肢麻痹。拟进行实验以进一步探讨 Bcl-2 和 Bax 在层粘连蛋白 a2 缺陷型肌肉病理进展中的作用,并确定它们在疾病早期和晚期对细胞凋亡、再生和存活的影响。我们还将检查正常和层粘连蛋白 a2 缺陷的肌肉细胞中其他凋亡调节分子的表达,特别是 FLIPL、ARC、XIAP 和 Apaf-1。这些蛋白质的表达将在体内通过实验改变,以确定它们是否可以调节层粘连蛋白u2缺陷肌肉的存活,以及是否可以通过改变其水平在不同阶段调节疾病进展。这些结果将进一步加深我们对层粘连蛋白 a2 缺陷型肌肉变性过程中控制细胞凋亡过程的机制的理解,并可能确定可作为人类 MCMD 治疗干预目标的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Janice A Dominov其他文献
Janice A Dominov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Janice A Dominov', 18)}}的其他基金
Apoptosis in Laminin alpha2-Deficient Muscle Pathology
层粘连蛋白 α2 缺陷的肌肉病理学中的细胞凋亡
- 批准号:
7647582 - 财政年份:2005
- 资助金额:
$ 36.61万 - 项目类别:
Apoptosis in Laminin alpha2-Deficient Muscle Pathology
层粘连蛋白 α2 缺陷的肌肉病理学中的细胞凋亡
- 批准号:
6925163 - 财政年份:2005
- 资助金额:
$ 36.61万 - 项目类别:
Apoptosis in Laminin alpha2-Deficient Muscle Pathology
层粘连蛋白 α2 缺陷的肌肉病理学中的细胞凋亡
- 批准号:
7597067 - 财政年份:2005
- 资助金额:
$ 36.61万 - 项目类别:
Apoptosis in Laminin alpha2-Deficient Muscle Pathology
层粘连蛋白 α2 缺陷的肌肉病理学中的细胞凋亡
- 批准号:
7046786 - 财政年份:2005
- 资助金额:
$ 36.61万 - 项目类别:
Apoptosis in Laminin alpha2-Deficient Muscle Pathology
层粘连蛋白 α2 缺陷的肌肉病理学中的细胞凋亡
- 批准号:
7393235 - 财政年份:2005
- 资助金额:
$ 36.61万 - 项目类别:
Apoptosis in Laminin alpha2-Deficient Muscle Pathology
层粘连蛋白 α2 缺陷的肌肉病理学中的细胞凋亡
- 批准号:
7424110 - 财政年份:2005
- 资助金额:
$ 36.61万 - 项目类别:
THE ROLE OF BCL-2 IN SKELETAL MUSCLE STEM CELLS
BCL-2 在骨骼肌干细胞中的作用
- 批准号:
6171701 - 财政年份:1998
- 资助金额:
$ 36.61万 - 项目类别:
相似海外基金
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development
多功能纳米颗粒平台可预防酒精相关的 HCC 发展
- 批准号:
10736984 - 财政年份:2023
- 资助金额:
$ 36.61万 - 项目类别:
Early Onset Parkinson’s disease subtypes and pathogenic mechanisms
早发性帕金森病亚型及致病机制
- 批准号:
10719645 - 财政年份:2023
- 资助金额:
$ 36.61万 - 项目类别:
MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among YMSM
MyPEEPS Mobile LITE:MyPEEPS Mobile 的有限交互功效试验可降低 YMSM 中的 HIV 发病率并更好地了解 HIV 流行病学
- 批准号:
10462265 - 财政年份:2022
- 资助金额:
$ 36.61万 - 项目类别:
Genetic Associations of Ischemic Heart Disease and Symptoms Among Diverse Postmenopausal Women
不同绝经后妇女缺血性心脏病和症状的遗传关联
- 批准号:
10450934 - 财政年份:2022
- 资助金额:
$ 36.61万 - 项目类别:
Social Stressors, Epigenetics and Health Status in Underrepresented minorities
代表性不足的少数群体的社会压力源、表观遗传学和健康状况
- 批准号:
10523174 - 财政年份:2022
- 资助金额:
$ 36.61万 - 项目类别: